12/12/2023 0 Comments Gsam battery monitor pro 3.34The rules of control in the discharge from radio-isotope hospital were notified in 1999 in Japan. Radio-iodine ( 131 I) therapy has been using in Graves' disease and well differentiated thyroid cancer. Guide-line of the radio-iodine ( 131 I) therapy in Graves' disease and thyroid cancer The therapy with 131 I on an outpatient basis is not suitable in patients with thyroid volume more than 40 ml. Radioiodine 131 I is effective and safe in the treatment of hyperthyroidism and the therapy on an outpatient basis is much cheaper choice. If we compared financial costs in model with 1 patient, we found that the costs of radioiodine therapy on an outpatient basis (118.7 €) comprise only 16 % of the costs of radioiodine therapy in hospitalization (728 €) and only 25 % of the costs of surgery (475.6 €). In 1 patient thyroid associated ophthalmopathy was moderately worsened. Patients with ineffective or only partially effective treatment had median of thyroid volume more than 40 ml. The effect of the treatment did not depend on the etiology and severity of hyperthyroidism, but decreased with thyroid volume. In 2/32 (6 %) patients the treatment was ineffective. After the treatment, 9/32 (28 %) patients were euthyroid without thyrostatic/thyroxine treatment, 18/32 (60 %) patients were hypothyroid with thyroxine therapy, 2/32 (6 %) patients significantly decreased doses of thyrostatic drugs. We also compared financial costs of the radioiodine treatment on an outpatient basis with the treatment in hospitalization and with surgery. In 32 of them we evaluated effectiveness and complications of therapy after 12-42 months. Capsule with 550 MBq of 131 I was administered orally in 39 hyperthyroid patients (32 women and 8 men, 21 with autoimmune Graves hyperthyroidism and 18 with toxic thyroid nodules, mean age 66.8 years). Our work is the first analysis of the experiences with radioiodine therapy of hyperthyroidism on an outpatient basis in Czech Republic. In Czech Republic, however, radioiodine therapy is still not enough used, and has been realized on an inpatient basis to date. Radioiodine 131 I therapy of hyperthyroidism on an outpatient basis is widely accepted over the world. The management of patients before and after I- 131 treatment is discussed as well as posttreatment hypothyroidism and complications of radioiodine treatment The technical aspects of radioiodine administration reviewed in this chapter include the biologic basis of I- 131 use, dose strategies, measurement and evaluation of radioiodine parameters, and I-125 treatment of hyperthyroidism. Some controversy exists concerning the use of I- 131 in children and adolescents as well as in some patients with toxic nodular goiter. Radioiodine appears to be increasingly selected as the primary form of therapy for most hyperthyroid adults. (author)Ĭurrent status of radioiodine ( 131 I) treatment of hyperthyroidism Patients who undergo I- 131 radioiodine therapy, especially those with cervical lesions, should be carefully monitored for this rare complication after treatment. All patients showed improvements without after-effects. Emergency tracheostomy was performed to treat the respiratory failure in one case while the others were treated conservatively. All cases involved relapsed cervical lesions, and two showed edema of the larynx. We report three cases of respiratory failure after I- 131 radioiodine therapy. Watanabe, Ken Uchiyama, Masayuki Fukuda, Kunihiko International Nuclear Information System (INIS) Three cases of respiratory failure after I- 131 radioiodine therapy
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |